>GAIDFPLK_00001 hypothetical protein
MENTINESGKKKRFKLKMPGAFMILFILTVVAVIATWVIPAGAYSKLSYEPSSQELKIVN
PHNQVKKVPGTQQELDKMGVKIKIEQFKSGAINKPVSIPNTYERLKQHPAGPEQITSSMV
EGTIEAVDIMVFILVLGGLIGVVQASGSFESGLLALTKKTKGHEFMLIVFVSILMIIGGT
LCGIEEEAVAFYPILVPIFIALGYDSIVSVGAIFLASSVGSTFSTINPFSVVIASNAAGT
TFTDGLYWRIGACIVGAIFVISYLYWYCKKIKKDPKASYSYEDKDAFEQQWSVLKDDDSA
HFTLRKKIILTLFVLPFPIMVWGVMTQGWWFPVMASAFLIFAIIIMFIAGTGKSGLGEKG
TVDAFVNGASSLVGVSLIIGLARGINLVLNEGMISDTILHFSSSLVQHMSGPLFIIVLLF
IFFCLGFIVPSSSGLAVLSMPIFAPLADTVGIPRFVIVTTYQFGQYAMLFLAPTGLVMAT
LQMLNMRYSHWFRFVWPVVAFVLIFGGGVLITQVLIYS
>GAIDFPLK_00002 Carbamate kinase 1
MMAKIVVALGGNALGKSPQEQLELVKNTAKSLVGLITKGHEIVISHGNGPQVGSINLGLN
YAAEHNQGPAFPFAECGAMSQAYIGYQLQESLQNELHSIGMDKQVVTLVTQVEVNENDPA
FNNPSKPIGLFYNKEEAEQIQKEKGFIFVEDAGRGYRRVVPSPQPISIIELESIKTLIKN
DTLVIAAGGGGIPVIREQHDGFKGIDAVIDKDKTSALLGANIQCDQLIILTAIDYVYINF
NTENQQPLETTNVDELKRYIDENQFAKGSMLPKIEAAISFIENNPKGSVLITSLNELDAA
LEGKVGTVIKK
>GAIDFPLK_00003 Ornithine carbamoyltransferase
MKNLRNRSFLTLLDFSRQEVEFLLTLSEDLKRAKYIGTEKPMLKNKNIALLFEKDSTRTR
CAFEVAAHDQGANVTYLGPTGSQMGKKETTKDTARVLGGMYDGIEYRGFSQRTVETLAEY
SGVPVWNGLTDEDHPTQVLADFLTAKEVLKKDYADINFTYVGDGRNNVANALMQGAAIMG
MNFHLVCPKELNPTDELLNRCKNIAAENGGNILITDDIDQGVKGSDVIYTDVWVSMGEPD
EVWKERLELLKPYQVNKEMMDKTGNPNVIFEHCLPSFHNADTKIGQQIFEKYGIREMEVT
DEVFESKASVVFQEAENRMHTIKAVMVATLGEF
>GAIDFPLK_00004 Superantigen-like protein 13
MKKNIMNKLVLSTALLLLGTTSTQLPKTPISFSSEAKAYNISENETNINELIKYYTQPHF
SLSGKWLWQKPNGSIHATLQTWVWYSHIQVFGAESWGNINQLRDKYVDIFGTKDEDTVEG
YWTYDETFTGGVTPAATSSDKSYKLFLKYSDKQQTIIGGLEFYKGNKPVLTLKELDFRIR
QTLINNKKLYNGEFNKGQIKITGGGNNYTIDLSKKLKLTDTNRYVKNPRHAEIEVILEKS
N
>GAIDFPLK_00005 Superantigen-like protein 13
MKKNITKKIILSSALLLLGAVSTQLPNTPISSKSEAKAYYINQEETNVSELIKYYTQQHL
TFSNKWLWQKDNGTIHATLLQISWYSHIQVFGPESWGNINQLRDKYVDIFGIKDQETIDS
YALSQETFTGGVTPAAKPNDKHYKLNVTYKDKDETFIGGYPFYTGNKPVLTLKEVDFRIR
QTLIKNKKLYQDKYNKGQLTITGDDNNYTIDLSKRLPSTDANKYVKNPQNAKIEVTLEKS
N
>GAIDFPLK_00006 Superantigen-like protein 13
MINPQKGDVQMKKNITNKIILTATLLILGTSSAQLPNTPIGFSSEAKAYHIGQDETNINE
LIKYYTQKPLTFSNRWLYQYDDGNIYVEFKRYSWSAHIRLWGAESWGNINQLRDRYVDVF
GLKDKDTRRLWWVYTDTFTGGVTPAASSSDKPYNIYVQYKDKLQTFIGAHKIYQGNKPVL
TLKEIDFRVRESLIKNKILYNENRNKGNIHITGGGNNFTIDLSKRLHSDLANVYVKNPQK
ITVEVLID
>GAIDFPLK_00007 hypothetical protein
MGWGPNTEADEKSAYNNVQVGDGPQHREFQKEILQTMQVGAAPNTENDFAFLLDSKSHLI
FCVLI
>GAIDFPLK_00008 hypothetical protein
MKELNEIINAIQFLFESESGYKISKNSGVPYQTVQDLRNGKTKIEDARFRTIIKLYSYYA
TLKEQ
>GAIDFPLK_00009 Alpha-hemolysin
MKTRIVSSVTTTLLLGSILMNPVANAADSDINIKTGTTDIGSNTIVKTGDLVTYDKENGM
HKKVFYSFIDDKNHNKKILVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNE
VAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDSGKIGGLIGANVSIGHTLKYVQPDFK
TILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPN
KASSLLSSGFSPDFATVITMDRKATKQQSNIDVIYERVRDDYQLHWTSTNWKGTNTKDKW
TDRSSERYKIDWEKEEMTN
>GAIDFPLK_00010 hypothetical protein
MVFKDWKVNVVYTGKHEVVTNENNLFVIDEDYDVAIAINYIDNKLKVSHVNYGSEFTIDS
SNKVLELMIHNPNIDEN
>GAIDFPLK_00011 hypothetical protein
MNKHINKKTTKHLEDYKKVQQRNSEETNRGCLKSVAMLIVLFLFIIFGIVACSTHVNFFF
Q
>GAIDFPLK_00012 hypothetical protein
MSNEYTIIGETNTNIIVRNVMHKIALYNLKNIYNAPIDKIKCCKKRSEYYSISILLEEKV
NVCRTCHNTKYNE
>GAIDFPLK_00013 Staphylococcal complement inhibitor
MKIKKYIVAGTLAVLLSTTAVSTLNGNKAEASSYDNYLTQSKYHDKKIAEELKSLLRQSN
VYDLAAGSLNRYYKRTIMMNEYRAKAALKKNDFKSMAEAKVGLENIYKEIDEIINR
>GAIDFPLK_00014 Fibrinogen-binding protein
MTYGPREKKPVSINHNIVEYNDGTFKYQSRPKFNSTPKYIKFRHDYNIVEYNDGTFGYGP
RPHFNKPAAKTDATIKKEQKLIQAQNLVREFEKTHTVSAHRKAQKAVNLVSFEYNVKKMI
LQERIDEVLKQGLVR
